| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YMGME.2019.10.013 |
| P698 | PubMed publication ID | 31704237 |
| P50 | author | Patryk Lipinski | Q60612886 |
| Anna Tylki-Szymańska | Q58108766 | ||
| P2093 | author name string | Piotr Socha | |
| Paulina Szymańska-Rożek | |||
| P2860 | cites work | Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C | Q61764154 |
| Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease | Q64043673 | ||
| Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis | Q64065840 | ||
| Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease | Q84869991 | ||
| The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease | Q88000713 | ||
| Diagnostic Performance of Transient Elastography for Liver Fibrosis in Children: A Systematic Review and Meta-Analysis | Q90938891 | ||
| Hepatocellular carcinoma in Gaucher disease: Reinforcing the proposed guidelines | Q93182248 | ||
| Therapeutic goals in the treatment of Gaucher disease. | Q33363129 | ||
| Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry | Q33438029 | ||
| Liver biopsy | Q33932981 | ||
| Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage | Q34647861 | ||
| Nonalcoholic fatty liver disease: from steatosis to cirrhosis | Q36382279 | ||
| Influencing factors of transient elastography in detecting liver stiffness | Q37288731 | ||
| Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease | Q39007048 | ||
| Liver involvement in Gaucher disease - Review and clinical approach | Q39008480 | ||
| Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment | Q47805142 | ||
| Causes of death in 184 patients with type 1 Gaucher disease from the United States who were never treated with enzyme replacement therapy. | Q48036939 | ||
| Hepatocellular carcinoma in Gaucher disease: an international case series. | Q48501252 | ||
| Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement | Q49990541 | ||
| Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease. | Q51127427 | ||
| Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. | Q51655382 | ||
| An unexpected player in Gaucher disease: The multiple roles of complement in disease development. | Q52373214 | ||
| Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience. | Q54229942 | ||
| Are transient and shear wave elastography useful tools in Gaucher disease? | Q54618737 | ||
| P433 | issue | 2 | |
| P921 | main subject | Gaucher's disease | Q861645 |
| P304 | page(s) | 125-131 | |
| P577 | publication date | 2019-11-01 | |
| P1433 | published in | Molecular Genetics and Metabolism | Q6895949 |
| P1476 | title | Controlled attenuation parameter and liver stiffness measurements using transient elastography by FibroScan in Gaucher disease | |
| P478 | volume | 129 |
Search more.